- Home
- UONEK vs NRSN Comparison
UONEK vs NRSN Comparison
Compare UONEK & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UONEK
- NRSN
- Stock Information
- Founded
- UONEK 1980
- NRSN 2017
- Country
- UONEK United States
- NRSN Israel
- Employees
- UONEK N/A
- NRSN N/A
- Industry
- UONEK Broadcasting
- NRSN Biotechnology: Pharmaceutical Preparations
- Sector
- UONEK Consumer Discretionary
- NRSN Health Care
- Exchange
- UONEK Nasdaq
- NRSN Nasdaq
- Market Cap
- UONEK 28.1M
- NRSN 26.0M
- IPO Year
- UONEK N/A
- NRSN 2021
- Fundamental
- Price
- UONEK $0.80
- NRSN $1.16
- Analyst Decision
- UONEK
- NRSN Buy
- Analyst Count
- UONEK 0
- NRSN 2
- Target Price
- UONEK N/A
- NRSN $14.00
- AVG Volume (30 Days)
- UONEK 25.4K
- NRSN 1.4M
- Earning Date
- UONEK 11-06-2025
- NRSN 09-17-2025
- Dividend Yield
- UONEK N/A
- NRSN N/A
- EPS Growth
- UONEK N/A
- NRSN N/A
- EPS
- UONEK N/A
- NRSN N/A
- Revenue
- UONEK $411,386,000.00
- NRSN N/A
- Revenue This Year
- UONEK N/A
- NRSN N/A
- Revenue Next Year
- UONEK N/A
- NRSN N/A
- P/E Ratio
- UONEK N/A
- NRSN N/A
- Revenue Growth
- UONEK N/A
- NRSN N/A
- 52 Week Low
- UONEK $0.44
- NRSN $0.80
- 52 Week High
- UONEK $1.40
- NRSN $2.60
- Technical
- Relative Strength Index (RSI)
- UONEK 52.13
- NRSN 45.23
- Support Level
- UONEK $0.74
- NRSN $1.14
- Resistance Level
- UONEK $1.00
- NRSN $1.28
- Average True Range (ATR)
- UONEK 0.11
- NRSN 0.15
- MACD
- UONEK -0.01
- NRSN 0.03
- Stochastic Oscillator
- UONEK 34.97
- NRSN 20.39
About UONEK Urban One Inc. Class D
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.